18 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
to oversee and direct the Company’s business. To that end, the Committee has identified and evaluated nominees in the broader context of the Board’s overall … , select and oversee management, and establish and oversee processes to maintain our integrity. Our Audit Committee has the responsibility to consider
DEF 14A
g57wd6 bt
27 Apr 22
Definitive proxy
5:03pm
10-K
isw1s
28 Mar 22
Annual report
4:51pm
10-Q
4hcs1n
16 Aug 21
Quarterly report
4:51pm
424B4
6ljlt3
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.1
0nmv4xa
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
5tgrcqr6xgo3d74hq
24 Jun 21
IPO registration (amended)
8:17am
S-1
EX-10.1
qjgu 19emwcqlb94l
9 Jun 21
IPO registration
5:02pm
S-1
5iqf64dygjg0stsn8h
9 Jun 21
IPO registration
5:02pm
DRS/A
EX-10.1
kraai8to nik7bqj
3 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
tl1r62pd2
14 May 21
Draft registration statement (amended)
12:00am
DRS
zrgiwxkps3mxgeh9g
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next